Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wall Street
Biotech
CG sets new bar in bladder cancer, months after huge IPO
CG plans to file a new drug application for its bladder cancer treatment in 2025.
Max Bayer
May 3, 2024 11:23am
Kyverna CEO: 'We're in the next phase of medicine'
Feb 9, 2024 1:57pm
Alto aims for $101M IPO to pave neuro development climb
Jan 30, 2024 11:37am
Cargo, undeterred by market challenges, seeks $281M IPO
Nov 10, 2023 10:00am
Two biotechs go public while Apnimed bides its time
Oct 2, 2023 11:02am
Affini-T plans to go public in 2024
Jul 25, 2023 2:42pm